miR-181c directly repressed MST1, LATS2, MOB1 and SAV1, leading to YAP/TAZ activation and subsequent promotion of pancreatic cancer cell survival and chemoresistance in vitro and in vivo. The gene discussed is LATS2; the disease is pancreatic neoplasm.